These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2167349)

  • 1. Inhibition of hepatitis A virus replication in vitro by antiviral compounds.
    Crance JM; Biziagos E; Passagot J; van Cuyck-Gandré H; Deloince R
    J Med Virol; 1990 Jun; 31(2):155-60. PubMed ID: 2167349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on mechanism of action of glycyrrhizin against hepatitis A virus replication in vitro.
    Crance JM; Lévêque F; Biziagos E; van Cuyck-Gandré H; Jouan A; Deloince R
    Antiviral Res; 1994 Jan; 23(1):63-76. PubMed ID: 8141593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of recombinant interferon-alpha on hepatitis A virus replication in human liver cells.
    Crance JM; Lévêque F; Chousterman S; Jouan A; Trépo C; Deloince R
    Antiviral Res; 1995 Sep; 28(1):69-80. PubMed ID: 8585761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antiviral substances on hepatitis A virus replication in vitro.
    Biziagos E; Crance JM; Passagot J; Deloince R
    J Med Virol; 1987 May; 22(1):57-66. PubMed ID: 3035080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus.
    Widell A; Hansson BG; Oberg B; Nordenfelt E
    Antiviral Res; 1986 Mar; 6(2):103-12. PubMed ID: 3010855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral activity of carrageenan on hepatitis A virus replication in cell culture.
    Girond S; Crance JM; Van Cuyck-Gandre H; Renaudet J; Deloince R
    Res Virol; 1991; 142(4):261-70. PubMed ID: 1665574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antiviral effect of recombinant interferon-alpha on hepatitis A virus replication in human liver cells].
    Crance JM; Deloince R; Leveque F; Jouan A; Trépo C
    C R Acad Sci III; 1994 Jan; 317(1):94-7. PubMed ID: 7987698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the expression of hepatitis A and B viruses (HAV and HBV) proteins by interferon in a human hepatocarcinoma cell line (PLC/PRF/5).
    Berthillon P; Crance JM; Leveque F; Jouan A; Petit MA; Deloince R; Trepo C
    J Hepatol; 1996 Jul; 25(1):15-9. PubMed ID: 8836896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glutaraldehyde on the antigenicity and infectivity of hepatitis A virus.
    Passagot J; Crance JM; Biziagos E; Laveran H; Agbalika F; Deloince R
    J Virol Methods; 1987 May; 16(1-2):21-8. PubMed ID: 3038939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro.
    Siegl G; Eggers HJ
    J Gen Virol; 1982 Jul; 61 (Pt l)():111-4. PubMed ID: 6288846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and propagation of hepatitis A virus in hepatoma cell cultures.
    Friedman-Alvermann B; Müller D; Spies K
    Acta Virol; 1985 Dec; 29(6):482-6. PubMed ID: 2869659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of selected antiviral compounds on measles (SSPE) virus replication in vitro.
    Hosoya M; Shigeta S; Nakamura K; De Clercq E
    Antiviral Res; 1989 Sep; 12(2):87-97. PubMed ID: 2480744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of atropine, protamine, and their combination on hepatitis A virus replication in PLC/PRF/5 cells.
    Biziagos E; Crance JM; Passagot J; Deloince R
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1112-7. PubMed ID: 2168143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of sandfly fever Sicilian virus (Phlebovirus) replication in vitro by antiviral compounds.
    Crance JM; Gratier D; Guimet J; Jouan A
    Res Virol; 1997; 148(5):353-65. PubMed ID: 9403935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examination of potential inhibitors of hepatitis A virus uncoating.
    Bishop NE
    Intervirology; 1998; 41(6):261-71. PubMed ID: 10325536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro.
    Kawana F; Shigeta S; Hosoya M; Suzuki H; De Clercq E
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1225-30. PubMed ID: 3307618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus.
    Superti F; Seganti L; Orsi N; Divizia M; Gabrieli R; Panà A; Stein ML
    Antiviral Res; 1989; 11(5-6):247-54. PubMed ID: 2552913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus replication is directly inhibited by IFN-alpha in a full-length binary expression system.
    Chung RT; He W; Saquib A; Contreras AM; Xavier RJ; Chawla A; Wang TC; Schmidt EV
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9847-52. PubMed ID: 11493707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propagation and assay of hepatitis A virus in vitro.
    Siegl G; deChastonay J; Kronauer G
    J Virol Methods; 1984 Aug; 9(1):53-67. PubMed ID: 6094609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effects on HAV IRES-mediated translation and replication by a combination of amantadine and interferon-alpha.
    Yang L; Kiyohara T; Kanda T; Imazeki F; Fujiwara K; Gauss-Müller V; Ishii K; Wakita T; Yokosuka O
    Virol J; 2010 Sep; 7():212. PubMed ID: 20815893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.